Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.
Parathyroid carcinoma is rare and the associated hypercalcaemia is often resistant to all treatment. A case is described in which prolonged control of hypercalcaemia has been achieved by infrequent infusions of pamidronate despite continuing hypersecretion of parathyroid hormone.
Newrick
P G
PG
Department of Medicine, Bristol Royal Infirmary, UK.
Braatvedt
G D
GD
Webb
A J
AJ
Sheffield
E
E
Corrall
R J
RJ
D002118:Calcium / Q000097:blood; D002277:Carcinoma / Q000097:blood / Q000150:complications*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy*; D008875:Middle Aged; D000077268:Pamidronate; D010281:Parathyroid Hormone / Q000097:blood; D010282:Parathyroid Neoplasms / Q000097:blood / Q000150:complications*; D013997:Time Factors
D004164:Diphosphonates; D010281:Parathyroid Hormone; D000077268:Pamidronate; D002118:Calcium